You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Details for Patent: 8,221,778


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,221,778 protect, and when does it expire?

Patent 8,221,778 protects UZEDY and is included in one NDA.

This patent has twenty-eight patent family members in eight countries.

Summary for Patent: 8,221,778
Title:Drug-containing implants and methods of use thereof
Abstract:The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.
Inventor(s):Siegel Steven, Winey Karen
Assignee:The Trustees of the University of Pennsylvania
Application Number:US11183232
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 8,221,778

Introduction

United States Patent 8,221,778, titled "Drug-containing implants and methods of use thereof," is a significant patent in the field of medical devices and pharmaceuticals. This patent, issued to innovators in the healthcare sector, outlines the design, composition, and application of drug-containing implants. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication and Filing Details

The patent was published on July 17, 2012, with the application number US11/183,232. It was granted on July 17, 2012, and is currently active, although its expiration date is a critical factor to consider for those interested in the technology[4].

Inventors and Assignees

Understanding the inventors and assignees is crucial for grasping the ownership and potential licensing or collaboration opportunities. However, specific details about the inventors and assignees are not provided in the sources, but they can be found in the full patent document.

Scope of the Invention

Drug-Containing Implants

The patent describes implants that contain a therapeutic drug and a polymer matrix, specifically polylactic acid (PLA) and optionally polyglycolic acid (PGA). These biodegradable polymers are designed to release the therapeutic drug over a period, providing a sustained delivery system[4].

Therapeutic Applications

The implants are intended for various therapeutic applications, including the treatment of conditions such as schizophrenia. The patent mentions specific drugs like risperidone and haloperidol, which are commonly used in psychiatric treatments[4].

Claims of the Patent

Independent and Dependent Claims

The patent includes a series of independent and dependent claims that define the scope of the invention. Independent claims typically outline the broadest aspects of the invention, while dependent claims narrow down the scope by adding specific details.

  • Independent Claims: These claims define the core elements of the drug-containing implants, such as the composition of the polymer matrix and the therapeutic drug.
  • Dependent Claims: These claims build upon the independent claims by specifying additional features, such as the method of manufacturing the implants, the release profile of the drug, and specific applications[4].

Key Claim Elements

  • Polymer Composition: The claims specify that the implants contain a polymer comprising polylactic acid (PLA) and optionally polyglycolic acid (PGA)[4].
  • Therapeutic Drug: The claims detail the inclusion of therapeutic drugs, such as risperidone and haloperidol, within the polymer matrix[4].
  • Method of Use: The patent claims also cover the methods of using these implants, including the administration and the expected therapeutic outcomes[4].

Patent Landscape

Prior Art and Citations

The patent landscape includes prior art cited by the inventors and other patent offices. The Common Citation Document (CCD) application, for instance, consolidates prior art citations from participating IP offices, providing a comprehensive view of the prior art landscape[1].

Related Patents and Applications

Other patents and applications related to drug-containing implants can be found through databases such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE® Search Service. These resources help in identifying similar inventions and understanding the competitive landscape[1].

Global Patent Family

Using the Global Dossier service, one can view the patent family for this specific application, including related applications filed at participating IP offices. This service provides insights into the global protection and status of the invention[1].

Search and Analysis Tools

USPTO Resources

The USPTO offers several tools for searching and analyzing patents, including the Patent Public Search tool, the Public Search Facility, and the Patent and Trademark Resource Centers (PTRCs). These resources are invaluable for conducting thorough searches and understanding the patent landscape[1].

International Databases

International databases such as those provided by the European Patent Office, Japan Patent Office, and the World Intellectual Property Organization are essential for a global patent search. These databases often include machine translations, which can be particularly useful for non-English speaking countries[1].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including those related to drug-containing implants. This dataset can be used to analyze trends and measurements of patent scope, offering insights into the economic and research implications of such patents[3].

Key Takeaways

  • Drug-Containing Implants: The patent covers implants with a polymer matrix containing PLA and optionally PGA, designed for sustained drug delivery.
  • Therapeutic Applications: The implants are intended for treating conditions like schizophrenia using drugs such as risperidone and haloperidol.
  • Claims and Scope: The patent includes independent and dependent claims defining the composition, method of use, and therapeutic outcomes.
  • Patent Landscape: The landscape includes prior art, related patents, and global patent family information accessible through various databases.
  • Search and Analysis Tools: Utilize USPTO resources and international databases for comprehensive patent searches.

FAQs

Q: What is the primary composition of the drug-containing implants described in US Patent 8,221,778?

A: The primary composition includes a polymer matrix of polylactic acid (PLA) and optionally polyglycolic acid (PGA), along with a therapeutic drug.

Q: What are the therapeutic applications of the implants described in the patent?

A: The implants are intended for treating conditions such as schizophrenia using drugs like risperidone and haloperidol.

Q: How can one search for related patents and prior art for this invention?

A: Use the USPTO's Patent Public Search tool, the Global Dossier service, and international databases like esp@cenet and PATENTSCOPE®.

Q: What tools are available for analyzing the economic and research implications of this patent?

A: The USPTO's Patent Claims Research Dataset provides detailed information on claims and patent scope measurements.

Q: Is the patent still active, and what is its expiration date?

A: The patent is currently active, but the exact expiration date needs to be verified from the patent document or relevant databases.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. PharmaCompass - US Patent 8221778: https://www.pharmacompass.com/us-patent-8221778
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US8221778B2: https://patents.google.com/patent/US8221778B2/en
  5. Unified Patents Portal - US-20220370620-A1: https://portal.unifiedpatents.com/patents/patent/US-20220370620-A1

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,221,778

Showing 1 to 6 of 6 entries

International Family Members for US Patent 8,221,778

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2005206143 ⤷  Try for Free
Australia 2006269927 ⤷  Try for Free
Canada 2553254 ⤷  Try for Free
Canada 2614601 ⤷  Try for Free
China 101287423 ⤷  Try for Free
China 103637977 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.